BioAge Labs, Inc.
NASDAQ:BIOABiotechnology
+$0.47 today
- Market cap
- $179.59M
- Beta
- 0.95
- P/E (TTM)
- -9.7
- EPS (TTM)
- -$2.12
Volume 0.64M
Average 0.46M
BIOA Long-term Investments
Investments the company intends to hold for more than a year.
BioAge Labs, Inc.NASDAQ: BIOA
Long-term Investments · Q1 FY2026 · quarter ended Mar 2026
Long-term investments falls 99.3% from a year ago
Long-term investments stood at $100K at the end of Q1 FY2026, down 99.3% from a year earlier and up 0.0% from the prior quarter.
Context
- Long-term investments amounted to 0.0% of total assets at the end of Q1 FY2026, down 4.2 pp from a year earlier.
- Long-term investments increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether long-term investments keeps falling in the next quarterly balance sheet after a -99.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 100K USD
- Year-over-year change
- +0.0%
| Period | Period end | Long-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 100K | +0.0% |
| FY2024 | 2024-12-31 | 100K | +0.0% |
| FY2023 | 2023-12-31 | 100K | — |
| FY2022 | 2022-12-31 | 0 | — |
Long-term Investments vs competitors
How BIOA compares with its peers on the latest reported figures
- Peers report in different currencies, so long-term investments is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -99.3% is the lowest of 5, against a peer median of -3.1%.
- Long-term investments amounts to 0.0% of total assets for BIOA, versus a peer median of 0.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CA$44.11M CAD | +25.0% | -35.8% | 3.9% | |
| Mar 2026 | CA$15.82M CAD | +202.7% | +4.8% | 2.6% | |
| Mar 2026 | $10.29M USD | -81.5% | -52.8% | 2.6% | |
| Mar 2026 | $2.67M USD | -31.1% | -69.3% | 1.8% | |
| Mar 2026 | $209K USD | — | — | 0.2% | |
BIOABioAge Labs, Inc. | Mar 2026 | $100K USD | -99.3% | — | 0.0% |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Dec 2025 | $0 USD | — | — | 0.0% | |
| Peer median (excluding BIOA) | — | -3.1% | -44.3% | 0.2% | |
Competitors are the stored peer set for BIOA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BioAge Labs, Inc.
NASDAQ:BIOA
Intrinsic Alpha fair value
Locked
Current Price
$4.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.